Methylated curcumin-resveratrol hybrid molecules for treating cancer

• US 8,350,093 B2
• Filed: 05/13/2010
• Issued: 01/08/2013
• Est. Priority Date: 02/12/2008
• Status: Active Grant

• Current Assignee: DePuy Synthes Products LLC (Johnson & Johnson)
• Original Assignee: Codman & Shurtleff Incorporated (Johnson & Johnson)
• Inventors: DiMauro, Thomas M.
• Primary Examiner(s): Sullivan, Daniel
• Assistant Examiner(s): LOVE, TREVOR M
• Application Number:
  US12/779,486
• Publication Number:
  US 20100292512A1
• Time in Patent Office: 971 Days
• Field of Search: 568/646, 514/720
• US Class Current: 568/646
• CPC Class Codes: A61K 31/12 Ketones
• CPC Class Codes: A61K 31/336 having three-membered rings, e.g. oxirane, fumagillin
• CPC Class Codes: A61K 9/0043 Nose
• CPC Class Codes: A61P 25/28 for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Abstract

Methylated curcumin-methoxystilbene hybrid molecules that have particular use in treating cancer.

Claims

1. 1,3-dimethoxyl 4,6-bis(4′

-methoxyl styryl) benzene.